The Cannigma

AUGUST 31, 2021

Barely a quarter of cannabis users trust their doctor to provide them with reliable information about medical cannabis and how to use it to treat their medical or health conditions, according to a recent survey. The respondents ranged in age from 19 to 81, and 50% identified as White, 20% as Latino, 12% as Asian, and 10% as Black.

Education

Cannabis Law Report

JULY 29, 2021

of their dry weight and it is not practical to obtain meaningful pure amounts of these compounds from the flesh of mushrooms, at a reasonable cost, to conduct clinical trials in humans and to commercialize these products. The levels of these compounds in dried mushrooms are only 0.2% – 1.0% Nova Mentis Life Science Corp.

Clinical Trials

Veriheal

MAY 12, 2021

In light of such, and the fact that cancer is a common qualifying condition for cannabis, this research team took to expanding the available basic information on cannabis in the cancer population in order to provide clinical trial designers with better information needed for planned studies.

Patients

Cannabis Law Report

AUGUST 19, 2021

Faced with booming sales, professor Sagnik Bhattacharyya, who researches psychotic and substance abuse disorders at King’s College London, says clinical trials are needed. “A change in policy to open up this valuable market and allow production will enable UK businesses to make the most of this global opportunity.”

Cannabinoids

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development

United Patients Group

JANUARY 8, 2023

Cannabis has been shown to be an effective treatment for a variety of conditions caused by bacteria, viruses and fungi. Many neurological conditions are associated with dysregulation of the ECS (for example: epilepsy, Parkinson’s disease). Cannabis has Antiviral, Antibacterial and Fungal Properties. We Need More Research.

Blood Pressure

Cannabis Law Report

JUNE 24, 2022

And the fact that the legislation is originating from leadership who is intimately familiar with drug policy reform is a firm indicator that this is a serious endeavor. Full story at. New Jersey Senate President Files Psilocybin Legalization Bill That Includes Home Grow Option, Unlike Current Marijuana Law.

Clinical Trials

Cannabis Law Report

NOVEMBER 19, 2021

“These additional patent filings are key as PsyBio moves towards the initiation of appropriately approved safety and efficacy clinical trials for our selected compounds within the production and manufacturing arena, for the Company as well as for our investors.” Vigorous scientific research and clinical trials are needed.

Clinical Trials

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Legalization

Cannabis Law Report

NOVEMBER 12, 2021

The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence. OCT is conducting pre-clinical testing and development with pre-clinical trials scheduled for 2022.

Cannabinoids

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. This is a policy where the federal government, the DEA, will refrain from taking prosecutorial action if state law permits, regulates, and carefully controls the use of a drug.

Therapy

Cannabis Law Report

OCTOBER 20, 2021

Critics of the policies point to the U.S. A House subcommittee asked the Department of Veterans Affairs directors why they didn’t support a bipartisan bill ordering the department to conduct clinical trials on the potential benefits of medical marijuana. That will be a big one that the appeals court will need to dive into.”

Hemp

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? For a drug to be approved by the FDA, it must go through Phase 1, 2, and 3 clinical trials. Co-author Dr Sue Sisley says that the results are promising.

Clinical Trials

MMJ Recs

MAY 9, 2024

Many veterans struggle with various physical and psychological conditions resulting from their service. These professionals can provide valuable insights into whether medical cannabis is a suitable option based on the veteran’s medical history, current conditions, and treatment goals.

Research and Development

Project CBD

FEBRUARY 28, 2023

Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. 17 Excerpted from HerbalGram , the quarterly publication of the American Botanical Council.

CBD

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law

Cannabis Law Report

APRIL 21, 2022

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. The State Government Affairs Lead will oversee MAPS PBC’s policy efforts at the state level. Executive Summary.

Advocacy

Cannabis Law Report

NOVEMBER 29, 2019

Lack of clinical trials is a major reason why doctors are cautious about the drug. Following Germany’s example, a number of other European countries developed policies granting patients easier access to medical cannabis. Read full story. EU should adopt German standards on medical cannabis, campaigners say.

Medicine

Cannabis Law Report

JANUARY 19, 2022

He understands that treatment and education for conditions such as Autism and Alzheimer’s disease have the potential to positively impact millions of lives. We look forward to his guidance in helping us bring new, THC-based investigational medications into FDA approved clinical trials. www.igcinc.us , www.igcpharma.com.

Clinical Trials

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Authors Tracy Gallegos and Neville M.

Business

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Experience in interpretation of regulations, guidelines, policy statements. Why work for MAPS Public Benefit Corporation (MAPS PBC)?

Research and Development

MMJ Recs

JULY 5, 2024

In states where it is legal, dispensaries report increasing sales of THC-infused products aimed at alleviating various health conditions. Understanding THC’s mechanisms and clinical implications is crucial as researchers continue to uncover its therapeutic potential and limitations in medical settings.

THC

Cannabis Info

OCTOBER 11, 2019

Dementia is a catch-all term for the conditions that cause declining memory and thinking skills, including Alzheimer’s, Parkinson’s and vascular dementia. In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. Cannabis research in the U.S.

Treatment

The Cannigma

JUNE 15, 2021

More and more CBD products on the market promise relief from pain, depression, anxiety, neurodegenerative conditions, and a plethora of other symptoms and conditions. Benzodiazepines are often prescribed for conditions such as anxiety, insomnia, seizure control, and muscle relaxation. Sonya Yruel/Drug Policy Alliance).

CBD

United Patients Group

JANUARY 5, 2023

A 2017 review of 10 clinical trials found that people who took probiotics had a 14% lower risk of contracting a cold or flu. Probiotics have been found to be useful in treating or preventing a number of conditions, including: Digestive disorders (such as inflammatory bowel disease). Probiotics May Reduce Flu Risk. Conclusion.

Digestion

Cannabis Law Report

SEPTEMBER 14, 2021

13, 2021 /PRNewswire-PRWeb/ — A host of scientific research and clinical trials around the world are affirming the remarkable effectiveness of psilocybin, the principal psychoactive component of “magic mushrooms,” in the treatment of a variety of medical conditions, including depression, anxiety, addiction, and PTSD.

Clinical Trials

Cannabis Law Report

JULY 13, 2019

clinical trials have been made by Members of Parliament. After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. CBD Testers.co However the problem in the U.K.

Research and Development

Cannabis Law Report

JUNE 9, 2022

The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin. “; 4) Article 11 shall be worded as follows: ” Article 11. .”;

Seed-To-Sale

Cannabis Law Report

JULY 23, 2019

LGC and its investors will benefit from a substantial competitive advantage through their knowledge and clinical trial capacity and its capacity to handle the regulatory compliance process for pharmaceuticals and food products,” said Mazen Haddad, CEO of LGC. LGC has also appointed two members to Freia’s board of directors.

Pharmaceutical

Cannabis Law Report

NOVEMBER 15, 2021

References: Statement from then FDA Commissioner Scott Gottlieb, MD, and Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies. News release. FDA website. January 15, 2019. 2021 Aug 26;23:119-127. doi: 10.1016/j.omtm.2021.08.006.

Research and Development

MMJ Recs

DECEMBER 22, 2023

Studies have shown the efficacy of medical cannabis in treating conditions such as chronic pain, epilepsy, and certain mental health disorders. The STATES Act, for example, represents a step toward allowing states to determine their cannabis policies without federal interference.

Marijuana

SpeedWeed

JULY 23, 2021

CBD produces a variety of effects by interacting with your endocannabinoid system in unique ways—it’s widely used by people suffering from a variety of conditions, including digestion, mood, and sleep issues. Consider nootropic supplements. Nootropics, sometimes called “smart pills,” are the hot new thing in supplements.

CBD

Cannabis Law Report

DECEMBER 20, 2021

Rule 154 6 of Drugs & Cosmetics Rules, 1945 states that- subject to the conditions of rule 157 being fulfilled, a licence to manufacture for sale any Ayurvedic (including Siddha) or Unani drugs shall be issued in Form 25D. The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules.

Seed-To-Sale

The Joint Blog

OCTOBER 21, 2020

Due to the updated hemp act being relatively new, lawmakers are still studying and formulating policies that can better improve the industry while regulating it for the safety of users. Users take Blosum’s CBD oil to alleviate all kinds of conditions. As the years go by, however, many locals demand a review of their local laws.

CBD

Cannabis Law Report

JULY 15, 2022

Different strains for different conditions. Different strains are grown to treat different medical conditions. The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care.

Medicine

MMJ Recs

AUGUST 1, 2024

While antiretroviral therapy (ART) has transformed HIV/AIDS from a fatal diagnosis to a manageable chronic condition, patients often endure chronic pain, nausea, appetite loss, and psychological distress. Medical marijuana, through its appetite-stimulating effects (often referred to as “the munchies”), can combat this condition.

Patients

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Spasticity from neurological conditions. Background. Conclusions. Bonini et al.

Research and Development